CURE’s Top Stories: October 2020

Each month, we take a look back at the most popular CURE® stories. Here are the top five for October 2020.

5. Penis Implants, Other Devices Help Improve Quality of Life in Men Following Prostate Cancer Treatment

Men may experience erectile dysfunction and incontinence after receiving treatment for prostate cancer. However, there are devices — like a penile prosthetic and artificial urinary sphincter — that can help control these side effects associated with treatment.

4. Legendary Guitarist Eddie Van Halen Dies from Cancer

Eddie Van Halen, the legendary lead guitarist for Van Halen, died at the age of 65 on Oct. 6 from cancer. Here, CURE® takes a look back at his life and the memories shared by those who knew and cared for him.

3. Adding Tukysa to Regimen for Metastatic HER2-Positive Breast Cancer Does Not Decrease Quality of Life

Adding the targeted drug Tukysa (tucatinib) to Herceptin (trastuzumab) and the chemotherapy Xeloda (capecitabine) lengthens life and time until disease progression in patients without decreasing their health-related quality of life, researchers found in a follow-up to the HER2CLIMB study.

2. Study Finds Cancer Center’s Patient and Staff Bathrooms Contaminated by Chemo Agents

Recent study results demonstrated that the patient and staff bathrooms of a cancer center were contaminated with frequently used chemotherapy agents, prompting researchers to call for improvements in the cleaning of the facilities so they would be safer for everyone.

1. Actor Sterling K. Brown is the Face of ‘Survivorship Today,’ Shedding Light on Life After Cancer

Through Bristol Myers Squibb’s ‘Survivorship Today,’ Sterling K. Brown — a star of the TV series “This Is Us” — has been interviewing cancer survivors about their journeys and the kinds of support they need. Here, he speaks with CURE® about why survivorship is an issue that’s close to his heart.

Thank you for reading!

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.